Effect of genetic variants GSTA1 and CYP39A1 and age on busulfan clearance in pediatric patients undergoing hematopoietic stem cell transplantation

Author(s):
Brink, M.H. ten; Bavel, T. van; Swen, J.J.; Straaten, T. van der; Bredius, R.G.M.; Lankester, A.C.; Zwaveling, J.; Guchelaar, H.J. (0000-0002-7085-1383)
Published
2013
Publication type
Article / Letter to editor
busulfanhematopoietic stem cell transplantationpediatric patientspharmacogeneticspharmacokinetics
Date issued
2013-11-30
Language
English
Is part of
Pharmacogenomics (2013), Vol. 14, no. 14, p. 1683-1690
hdl
1887/88245
doi
10.2217/pgs.13.159